News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,786 Results
Type
Article (8019)
Company Profile (142)
Press Release (478624)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166738)
Career Advice (302)
Deals (25738)
Drug Delivery (8)
Drug Development (52867)
Employer Resources (14)
FDA (9760)
Job Trends (8568)
News (238195)
Policy (17891)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (493)
Accelerated approval (27)
ADA (18)
Adcomms (1)
Allergies (100)
Alliances (33156)
ALS (115)
Alzheimer's disease (990)
Antibody-drug conjugate (ADC) (300)
Approvals (10436)
Artificial intelligence (346)
ASCO (160)
Autoimmune disease (230)
Automation (30)
Bankruptcy (263)
Belgium (3)
Best Places to Work (6958)
BIO (36)
Biologics (20)
BIOSECURE Act (1)
Biosimilars (120)
BioSpace Insights (17)
Biotechnology (90)
Bispecific (6)
Bladder cancer (140)
Brain cancer (33)
Breast cancer (524)
Cancer (3846)
Cardiovascular disease (230)
Career advice (245)
Career pathing (1)
CAR-T (183)
CDC (1)
CDMO (24)
Celiac Disease (1)
Cell therapy (499)
Cervical cancer (35)
Clinical research (48191)
Collaboration (1313)
Commercialization (8)
Compensation (1584)
Complete response letters (35)
COVID-19 (764)
CRISPR (65)
C-suite (825)
Cystic fibrosis (87)
Data (6027)
Denatured (4)
Depression (108)
Dermatology (83)
Diabetes (368)
Diagnostics (4230)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (164)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (172)
Earnings (73782)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88304)
Executive appointments (722)
Eye disease (1)
FDA (12574)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (974)
Gene editing (127)
Generative AI (11)
Gene therapy (341)
GLP-1 (299)
Government (948)
Grass and pollen (2)
Guidances (281)
Healthcare (9370)
Hematology (94)
HIV (55)
Huntington's disease (23)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (72)
Immunology and inflammation (111)
Immuno-oncology (63)
Indications (170)
Infectious disease (958)
Inflammatory bowel disease (131)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (267)
Interviews (41)
IPO (12390)
IRA (2)
Job creations (1969)
Job search strategy (235)
JPM (1)
Kidney cancer (17)
Kidney disease (56)
Layoffs (59)
Legal (5195)
Licensing (27)
Liver cancer (46)
Longevity (21)
Lung cancer (555)
Lung diease (8)
Lymphoma (263)
Machine learning (29)
Management (3)
Manufacturing (594)
Marketing (10)
MASH (118)
Medical affairs (2)
Medical device (8697)
Medtech (8862)
Mergers & acquisitions (14428)
Metabolic disorders (744)
mRNA (70)
Multiple sclerosis (107)
Multispecific (1)
NASH (4)
Netherlands (1)
Neurodegenerative disease (230)
Neuropsychiatric disorders (40)
Neuroscience (1895)
NextGen: Class of 2026 (3150)
Non-profit (843)
Obesity (235)
Opinion (10)
Ovarian cancer (172)
Pain (181)
Pancreatic cancer (215)
Parkinson's disease (212)
Partnered (12)
Patents (512)
Patient advocacy (1)
Patient recruitment (534)
Patient selection (16)
Peanut (33)
People (41429)
Peptides (6)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15561)
Phase 2 (21524)
Phase 3 (14524)
Pipeline (7980)
Policy (18)
Postmarket research (1570)
Preclinical (6568)
Press Release (34)
Prostate cancer (196)
Psychedelics (9)
Radiopharmaceuticals (199)
Rare diseases (605)
Real estate (3025)
Recruiting (6)
Regenerative medicine (8)
Regulatory (15072)
Reports (23)
Research institute (586)
Resumes & cover letters (45)
Rett syndrome (44)
RNA editing (8)
RSV (48)
Schizophrenia (105)
Series A (170)
Series B (125)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (91)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (52)
Vaccines (339)
Venture capital (17)
Weight loss (76)
Wet AMD (1)
Women's health (92)
Date
Today (91)
Last 7 days (411)
Last 30 days (1450)
Last 365 days (19133)
2026 (14412)
2025 (19251)
2024 (22976)
2023 (26538)
2022 (34573)
2021 (37150)
2020 (33470)
2019 (23258)
2018 (17468)
2017 (18744)
2016 (17898)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20202)
2011 (20426)
2010 (20316)
Location
Africa (229)
Alabama (80)
Alaska (2)
Arizona (314)
Arkansas (12)
Asia (18000)
Australia (2111)
California (12573)
Canada (3293)
China (557)
Colorado (509)
Connecticut (436)
Delaware (219)
Europe (24731)
Florida (1889)
Georgia (396)
Hawaii (3)
Idaho (46)
Illinois (745)
India (55)
Indiana (327)
Iowa (16)
Japan (440)
Kansas (104)
Kentucky (33)
Louisiana (27)
Maine (27)
Maryland (1249)
Massachusetts (8227)
Michigan (316)
Minnesota (581)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (125)
New Hampshire (60)
New Jersey (2751)
New Mexico (12)
New York (2948)
North Carolina (1328)
North Dakota (4)
Northern California (6337)
Ohio (299)
Oklahoma (14)
Oregon (16)
Pennsylvania (2338)
Puerto Rico (24)
Rhode Island (30)
South America (407)
South Carolina (79)
South Dakota (1)
Southern California (5241)
Tennessee (126)
Texas (2060)
United States (40719)
Utah (378)
Vermont (1)
Virginia (160)
Washington D.C. (39)
Washington State (968)
West Virginia (1)
Wisconsin (78)
Wyoming (1)
486,786 Results for "roosterbio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RoosterBio and Applied StemCell Partner to Advance Scalable iPSC-Based Bioprocess Solutions
July 8, 2026
·
5 min read
Press Releases
RoosterBio and Made Scientific Announce Strategic Technology and Supply Partnership to Expand Scalable MSC and Extracellular Vesicle Manufacturing
May 5, 2026
·
5 min read
Press Releases
Made Scientific and RoosterBio Announce Strategic Technology and Supply Partnership to Expand Scalable MSC and Extracellular Vesicle Manufacturing
May 5, 2026
·
5 min read
Press Releases
RoosterBio and MineBio Life Sciences Partner to Expand Access to Scalable, High Quality MSC and Exosome Bioprocessing Solutions in China
April 8, 2026
·
5 min read
Press Releases
RoosterBio and Secretome Therapeutics Announce Successful Completion of Large Scale Bioreactor Production for Clinical Stage Cell Therapy Candidate STM-01
October 7, 2025
·
4 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today a strategic partnership with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services.
August 16, 2022
·
4 min read
ShiftBio Partners with RoosterBio to Accelerate Development of a Novel Genetically Engineered Exosome, SBI-102 for Rare Diseases and Cancer
RoosterBio’s MSC-derived exosome bioprocess technology platform enables accelerated development of ShiftBio’s lead therapeutic candidate via a scalable cGMP manufacturing process in bioreactors, downstream purification, and analytical characterization.
April 26, 2022
·
4 min read
BioCapital
RoosterBio Partners with Senti Biosciences to Rapidly Translate Gene Circuit Cell Therapy into the ClinicCollaboration leverages cGMP clinical hMSC systems to accelerate gene modified cell therapy for solid tumors.
RoosterBio Inc. announces a clinical supply and manufacturing collaboration agreement with pioneering gene circuit company Senti Biosciences, Inc. (Senti) to accelerate the clinical translation of Senti’s gene-modified cell therapies for ovarian cancer and other solid tumor indications. The collaboration will leverage RoosterBio’s human mesenchymal stem/stromal cell (hMSC) bioprocess systems, rapid product and process development platform, and
March 17, 2020
·
3 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
1 of 48,679
Next
